An Immunity Persistence Study of Booster Dose of Live Attenuated Varicella Vaccine

Summary

This an open-label phase Ⅳ clinical trial of live attenuated varicella vaccine manufactured by Sinovac (Dalian) Vaccine Technology Co., Ltd.The purpose of this study is to evaluate the immunity persistence of live attenuated varicella vaccine at 6 and 10 years after booster dose.

Timeline

Start

2024-09-16

Primary completion

2028-12

Completion

2031-12

Drugs

Indications